Danija - danų - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm generics a/s - doxazosinmesilat - depottabletter - 4 mg

Danija - danų - Lægemiddelstyrelsen (Danish Medicines Agency)

accord healthcare b.v. - tadalafil - filmovertrukne tabletter - 5 mg

Europos Sąjunga - danų - EMA (European Medicines Agency)

krka, d.d., novo mesto - abiraterone acetat - prostatiske neoplasmer - endokrine terapi - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Danija - danų - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - doxazosinmesilat - depottabletter - 4 mg

Europos Sąjunga - danų - EMA (European Medicines Agency)

glaxosmithkline trading services - fluticasonfuroat, umeclidiniumbromid, vilanteroltrifenat - pulmonal sygdom, kronisk obstruktiv - medicin for obstruktiv sygdomme, - trelegy ellipta er angivet som en vedligeholdelsesbehandling af voksne patienter med moderat til svær kronisk obstruktiv lungesygdom (kol), der ikke er tilstrækkeligt behandlet med en kombination af et inhaleret binyrebarkhormon og en langtidsvirkende β2-agonist.

Europos Sąjunga - danų - EMA (European Medicines Agency)

accord healthcare s.l.u. - abiraterone acetat - prostatiske neoplasmer - endokrine terapi - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Danija - danų - Lægemiddelstyrelsen (Danish Medicines Agency)

teva b.v. - doxazosinmesilat - depottabletter - 4 mg

Danija - danų - Lægemiddelstyrelsen (Danish Medicines Agency)

stada arzneimittel ag - doxazosinmesilat - depottabletter - 4 mg

Danija - danų - Lægemiddelstyrelsen (Danish Medicines Agency)

stada arzneimittel ag - finasterid - filmovertrukne tabletter - 5 mg

Danija - danų - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - doxazosinmesilat - depottabletter - 4 mg